• 1
    Pappas G, Memish ZA. Brucellosis in the middle East: a persistent medical, socioeconomic and political issue. J Chemother 2007;19:2438.
  • 2
    Sofian M, Aghakhani A, Velayati AA, Banifazl M, Eslamifar A, Ramezani A. Risk factors for human brucellosis in Iran: a case-control study. Int J Infect Dis 2008;12:15761.
  • 3
    von Bargen K, Gorvel JP, Salcedo SP. Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol Rev 2012;36:53362.
  • 4
    Schurig GG, Sriranganathan N, Corbel MJ. Brucellosis vaccines: past, present and future. Vet Microbiol 2002;90:47996.
  • 5
    Rodriguez-Zapata M, Matias MJ, Prieto A et al. Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function. Infect Immun 2010;78:32729.
  • 6
    Makarem EH, Karjoo R, Omidi A. Frequency of Brucella melitensis in Southern Iran. J Trop Pediatr 1982;28:97100.
  • 7
    Ko J, Gendron-Fitzpatrick A, Splitter GA. Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis. J Immunol 2002;168:243340.
  • 8
    Ficht TA. Intracellular survival of Brucella: defining the link with persistence. Vet Microbiol 2003;92:21323.
  • 9
    Giambartolomei GH, Zwerdling A, Cassataro J, Bruno L, Fossati CA, Philipp MT. Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol 2004;173:463542.
  • 10
    Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP. The innate immune response against Brucella in humans. Vet Microbiol 2002;90:38394.
  • 11
    Stanilova S, Miteva L, Prakova G. Interleukin-12B-3'UTR polymorphism in association with IL-12p40 and IL-12p70 serum levels and silicosis severity. Int J Immunogenet 2007;34:1939.
  • 12
    Fernandez-Lago L, Rodriguez-Tarazona E, Vizcaino N. Differential secretion of interleukin-12 (IL-12) subunits and heterodimeric IL-12p70 protein by CD-1 mice and murine macrophages in response to intracellular infection by Brucella abortus. J Med Microbiol 1999;48:106573.
  • 13
    Morris GA, Edwards DR, Hill PC et al. Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia. Guinea-Bissau, United States and Argentina. PLOS ONE 2011;6:e16656.
  • 14
    Wang J, Tang S, Shen H. Association of genetic polymorphisms in the IL12-IFNG pathway with susceptibility to and prognosis of pulmonary tuberculosis in a Chinese population. Eur J Clin Microbiol Infect Dis 2010;29:12915.
  • 15
    Varade J, Comabella M, Ortiz MA et al. Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes. Mult Scler 2012;18:95965.
  • 16
    Marquez A, Mendoza JL, Taxonera C et al. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis 2008;14:11926.
  • 17
    Walsh JP, Berry J, Liu S et al. The clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotype. Clin Endocrinol (Oxf) 2011;74:50812.
  • 18
    Huffmeier U, Lascorz J, Bohm B et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol 2009;129:3558.
  • 19
    Hashemi M, Eskandari-Nasab E, Fazaeli A et al. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 2012;505:1769.
  • 20
    Lin DY, Huang BE. The use of inferred haplotypes in downstream analyses. Am J Hum Genet 2007;80:5779.
  • 21
    Lewontin RC. The detection of linkage disequilibrium in molecular sequence data. Genetics 1995;140:37788.
  • 22
    Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009;20:4359.
  • 23
    Cannella AP, Tsolis RM, Liang L et al. Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development. Front Cell Infect Microbiol 2012;2:1.
  • 24
    Chen S, Shimada K, Zhang W, Huang G, Crother TR, Arditi M. IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J Immunol 2010;185:561927.
  • 25
    Nigg AP, Zahn S, Ruckerl D et al. Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice. J Immunol 2007;178:72518.
  • 26
    Lu T, Newton C, Perkins I, Friedman H, Klein TW. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila. Eur J Pharmacol 2006;532:1707.
  • 27
    Lee IK, Olsen SC, Bolin CA. Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model. Can J Vet Res 2001;65:2238.
  • 28
    Navratilova Z, Gallo J, Mrazek F, Petrek M. Genetic variation in key molecules of the Th-17 immune response is not associated with risk for prosthetic joint infection in a Czech population. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156:24852.
  • 29
    Phawong C, Ouma C, Tangteerawatana P et al. Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adults. Immunogenetics 2010;62:34556.
  • 30
    Zielonka TM, Demkow U, Michalowska-Mitczuk D et al. Angiogenic activity of sera from pulmonary tuberculosis patients in relation to IL-12p40 and TNFalpha serum levels. Lung 2011;189:3517.
  • 31
    Handzel ZT, Barak V, Altman Y et al. Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. Isr Med Assoc J 2007;9:47983.
  • 32
    Rosinha GM, Myioshi A, Azevedo V, Splitter GA, Oliveira SC. Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation. J Med Microbiol 2002;51:66171.
  • 33
    Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol 2006;26:40742.
  • 34
    Yaghini N, Mahmoodi M, Hassanshahi G et al. Genetic variation of IL-12B (+1188 region) is associated with its decreased circulating levels and susceptibility to Type 2 diabetes. Biomark Med 2012;6:8995.
  • 35
    Kaarvatn MH, Vrbanec J, Kulic A et al. Single Nucleotide Polymorphism in the Interleukin 12B Gene is Associated with Risk for Breast Cancer Development. Scand J Immunol 2012;76:32935.
  • 36
    Nair RP, Ruether A, Stuart PE et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008;128:165361.
  • 37
    Wong RH, Wei JC, Huang CH et al. Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis. J Rheumatol 2012;39:13540.
  • 38
    Zhou L, Yao F, Luan H et al. Functional polymorphisms in the interleukin-12 gene contribute to cancer risk: Evidence from a meta-analysis of 18 case-control studies. Gene 2012;510:717.
  • 39
    Chen X, Han S, Wang S et al. Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res 2009;15:4005.
  • 40
    Tao YP, Wang WL, Li SY et al. Associations between polymorphisms in IL-12A, IL-12B, IL-12Rbeta1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. J Cancer Res Clin Oncol. 2012;138:1891900.
  • 41
    Roszak A, Mostowska A, Sowinska A, Lianeri M, Jagodzinski PP. Contribution of IL12A and IL12B Polymorphisms to the Risk of Cervical Cancer. Pathol Oncol Res 2012;18:9971002.
  • 42
    Wang EY, Liang WB, Zhang L. Association between single-nucleotide polymorphisms in interleukin-12A and risk of chronic obstructive pulmonary disease. DNA Cell Biol 2012;31:14759.
  • 43
    Morahan G, McKinnon E, Berry J et al. Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium. Genes Immun 2009;10(Suppl. 1):S648.
  • 44
    Franchim CS, Sass N, Mattar R et al. Inflammatory mediators gene polymorphisms in preeclampsia. Hypertens Pregnancy 2011;30:33846.
  • 45
    Eiris N, Santos-Juanes J, Coto-Segura P et al. Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes. Cytokine 2012;60:279.
  • 46
    Morahan G, Huang D, Ymer SI et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001;27:21821.
  • 47
    Latsi P, Pantelidis P, Vassilakis D, Sato H, Welsh KI, du Bois RM. Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis. Respir Res 2003;4:6.
  • 48
    Stanilova S, Miteva L. Taq-I polymorphism in 3'UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun 2005;6:3646.
  • 49
    Freidin MB, Rudko AA, Kolokolova OV, Strelis AK, Puzyrev VP. Association between the 1188 A/C polymorphism in the human IL12B gene and Th1-mediated infectious diseases. Int J Immunogenet 2006;33:2312.
  • 50
    Seegers D, Zwiers A, Strober W, Pena AS, Bouma G. A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002;3:41923.
  • 51
    Ong'echa JM, Raballah EO, Kempaiah PM et al. Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malaria. BMC Genet. 2011;12:69.
  • 52
    Liu S, Hou P, Morahan G, Shi B. No Association Between IL12B Gene Polymorphisms and Graves' Disease in the Chinese Population. Endocr Res 2012;37:1827.
  • 53
    Nair RP, Stuart PE, Kullavanijaya P, Tejasvi T, Voorhees JJ, Elder JT. Genetic evidence for involvement of the IL23 pathway in Thai psoriatics. Arch Dermatol Res 2010;302:13943.
  • 54
    Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR. IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population. Gastroenterol Res Pract 2010;2010:539461.